Pre-order Enquiry
Request Free Sample
Global CAS9 Technology Market Growth (Status and Outlook) 2022-2028
SKU ID : LPI-21163510 | Publishing Date : 30-Jun-2022 | No. of pages : 96
Request Sample
Request Customization
Check Discounts
According to this study, the global CAS9 Technology market size will reach US$ million by 2028.
This report presents a comprehensive overview, market shares, and growth opportunities of CAS9 Technology market by product type, application, key players and key regions and countries.
Segmentation by product type:
Genome Engineering
Disease Models
Segmentation by Application:
Biotechnology & Pharmaceutical Companies
Academic & Research Institutes
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Cellecta Inc.
abm Inc.
GenScript
CRISPR Therapeutic
Intellia Therapeutics Inc.
GE Healthcare
Takara Bio Inc.
AstraZeneca
PLC
Merck KGaA
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
New England Biolabs
OriGene Technologies Inc.
Lonza Group
Thermo Fisher Scientific
This report presents a comprehensive overview, market shares, and growth opportunities of CAS9 Technology market by product type, application, key players and key regions and countries.
Segmentation by product type:
Genome Engineering
Disease Models
Segmentation by Application:
Biotechnology & Pharmaceutical Companies
Academic & Research Institutes
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Cellecta Inc.
abm Inc.
GenScript
CRISPR Therapeutic
Intellia Therapeutics Inc.
GE Healthcare
Takara Bio Inc.
AstraZeneca
PLC
Merck KGaA
Bio-Rad Laboratories Inc.
Danaher Corporation (Integrated DNA Technologies Inc.)
New England Biolabs
OriGene Technologies Inc.
Lonza Group
Thermo Fisher Scientific
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
